Presynaptic regulation of the release of catecholamines
- PMID: 6267618
Presynaptic regulation of the release of catecholamines
Abstract
During norepinephrine release elecited by the arrival of nerve impulses, the neurotransmitter interacts with specific receptors (alpha1-, beta1-, beta2-adrenoceptors) located in the membrane of the postsynaptic cell to trigger the response of the effector organ. Until a few years ago, it was thought that the role of noradrenergic nerve terminals in neurotransmission is concerned exclusively with the synthesis, storage, release, and inactivation of norepinephrine and there were no indications that receptors might also be present in the presynaptic membrane. During the last decade, evidence has accumulated in favour of the view that, in addition to the classical postsynaptic adrenoceptors that mediate the responses of the effector organ, there are also receptors located on the noradrenergic nerve terminals. These presynaptic recptors are involved in the modulation of the calcium-dependent, action-potential-evoked release of norepinephrine in the peripheral as well as in the central nervous system. Presynaptic inhibitory alpha-adrenoceptors are involved in the regulation of the release of norepinephrine through a negative feedback mechanism mediated by the neuron's own transmitter. Alpha-Adrenoceptor agonists inhibit the release of norepinephrine during nerve stimulation, while alpha-adrenoceptor blocking agents enhance the stimulation-evoked release of the neurotransmitter. These results have been obtained both i vitro and in vivo. There are pharmacological differences between the postsynaptic alpha-adrenoceptors that mediate the response of the effector organ and the presynaptic inhibitory alpha-adrenoceptors that modulate the release of norepinephrine during nerve stimulation. The subclassification of alpha-adrenoceptors into alpha1- and alpha2-types is bases on differences in relative affinities for a range of alpha-adrenoceptor agoinst and antagonist durgs. The term alpha1-adrenceptor is used for a receptor that is preferentially stimulated by phenylephrine and blocked by prazosin, whereas alpha2-adrenoceptor is reserved for those preferentially stimulated by guanabenz or clonidine and blocked by rauwolscine or yohimbine. The presynaptic inhibitory alpha-adrenoceptors in the peripheral and in the central nervous system have the pharmacological characteristics of the alpha2-adrenoceptors. Presynaptic inhibiotry autoreceptors appear to be involved in the modulation of the release of dopamine and of epinephrine in the central nervous system. A short negative feedback mechanism similar to that for norepinephrine appears to regulate the stimulation-evoked release of dopamine and epinephrine in central neurons. In addition to presynaptic autoreceptors through which the transmitter can modulate its own release, a real mosaic of receptors in present on noradrenergic nerve endings...
Similar articles
-
Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.J Cardiovasc Pharmacol. 1985;7 Suppl 8:S1-8. J Cardiovasc Pharmacol. 1985. PMID: 2417042
-
Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.Hypertension. 1980 Jul-Aug;2(4):372-82. doi: 10.1161/01.hyp.2.4.372. Hypertension. 1980. PMID: 6105128 Review.
-
Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.Acta Physiol Scand Suppl. 1987;560:1-38. Acta Physiol Scand Suppl. 1987. PMID: 2884804
-
Evidence that noradrenergic transmitter release is regulated by presynaptic receptors.Fed Proc. 1984 Apr;43(5):1352-7. Fed Proc. 1984. PMID: 6142834 Review.
-
Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.J Pharmacol Exp Ther. 1985 May;233(2):459-65. J Pharmacol Exp Ther. 1985. PMID: 2987485
Cited by
-
Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.Br J Pharmacol. 1986 Dec;89(4):673-83. doi: 10.1111/j.1476-5381.1986.tb11171.x. Br J Pharmacol. 1986. PMID: 3028549 Free PMC article.
-
Regulation of sodium and body fluid homeostasis during development: implications for the pathogenesis of hypertension.Experientia. 1992 Apr 15;48(4):345-51. doi: 10.1007/BF01923428. Experientia. 1992. PMID: 1582493 Review.
-
Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):379-85. doi: 10.1007/BF00167038. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2555719
-
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.Br J Pharmacol. 1989 May;97(1):229-39. doi: 10.1111/j.1476-5381.1989.tb11946.x. Br J Pharmacol. 1989. PMID: 2566353 Free PMC article.
-
Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):271-82. doi: 10.1007/BF00251126. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1678140
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources